Related Experiment Video
Updated: Jun 20, 2026

04:14
In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
Published on: October 6, 2023
A possible mechanism for the decrease in serum thyroxine level by a 2,3,7,8-tetrachlorodibenzo-p-dioxin-like
Yoshihisa Kato1, Koichi Haraguchi, Makiko Kubota
1Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Sanuki, Kagawa, Japan. kato@kph.bunri-u.ac.jp
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|September 30, 2009
Summary
Polychlorinated biphenyls (PCBs) like CB126 decrease serum thyroxine (T4) by increasing liver enzymes that process T4. This effect is seen in sensitive mice, leading to liver changes.
Area of Science:
- Environmental Toxicology
- Endocrinology
- Pharmacology
Background:
- Polychlorinated biphenyls (PCBs) are environmental contaminants with known toxic effects.
- Thyroxine (T4) is a crucial thyroid hormone regulating metabolism.
- Differential sensitivity to toxic compounds exists between mouse strains.
Purpose of the Study:
- To investigate the mechanism by which 3,3',4,4',5-pentachlorobiphenyl (CB126) affects serum thyroxine (T4) levels.
- To compare the effects of CB126 on T4 metabolism in TCDD-sensitive and TCDD-resistant mice.
Main Methods:
- Administration of CB126 to C57BL/6 (TCDD-sensitive) and DBA/2 (TCDD-resistant) mice.
- Measurement of serum total and free T4 levels.
- Assay of hepatic T4-UDP-glucuronosyltransferase (T4-UGT) activity.
- Analysis of biliary excretion and serum clearance of radiolabeled T4.
- Assessment of liver weight and hepatic T4 accumulation.
Main Results:
- CB126 significantly decreased serum T4 levels in C57BL/6 mice but not in DBA/2 mice.
- Hepatic T4-UGT activity and T4 glucuronidation were significantly increased by CB126 in C57BL/6 mice.
- CB126 enhanced serum T4 clearance and biliary excretion of T4 glucuronide in C57BL/6 mice.
- Liver hypertrophy was observed in CB126-treated C57BL/6 mice, leading to increased hepatic T4 accumulation.
Conclusions:
- CB126-induced decrease in serum T4 is mediated by increased hepatic T4-UGT activity and enhanced T4 metabolism.
- Liver hypertrophy contributes to the altered T4 homeostasis observed in CB126-exposed sensitive mice.
- Mouse strain sensitivity plays a critical role in the toxicological response to CB126 regarding thyroid hormone disruption.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

